Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. - sprookjes - yvandenbroek - TriplyDB

Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

http://www.wikidata.org/entity/Q33196686

about

Kidney Injury Molecule-1 and Cardiovascular Diseases: From Basic Science to Clinical Practice Organ-specific responses to circulatory disturbances in heart failure: new insights The kidney in congestive heart failure: 'are natriuresis, sodium, and diuretics really the good, the bad and the ugly?'Cardiorenal syndrome: a cardiologist's perspective of pathophysiology Management of the cardiorenal syndrome in decompensated heart failure Cardio-renal syndrome Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure Adenosine receptors and the kidney The feasibility of a telephone coaching program on heart failure home management for family caregivers.Urinary Proteolytic Activation of Renal Epithelial Na+ Channels in Chronic Heart Failure.Effect of renal function on prognosis in chronic heart failure.Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry Association between human resources and risk of hospitalisation in end-stage renal disease outpatients receiving haemodialysis: a longitudinal cohort study using claim data during 2013-2014.Investigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trial Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial.Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure.Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failure.Early adverse events as predictors of 1-year mortality during mechanical circulatory support.Prognostic impact of renal dysfunction does not differ according to the clinical profiles of patients: insight from the acute decompensated heart failure syndromes (ATTEND) registry Neutrophil Gelatinase-Associated Lipocalin (NGAL) predicts renal injury in acute decompensated cardiac failure: a prospective observational study.Prevalence and clinical features of patients with the cardiorenal syndrome admitted to an internal medicine ward.Prognostic implications of renal dysfunction in patients hospitalized with heart failure: data from the last decade of clinical investigations.A patient with heart failure and worsening kidney function Acute and acute-on-chronic kidney injury of patients with decompensated heart failure: impact on outcomes.The cardiorenal syndrome: making the connection.Worsening renal function defined as an absolute increase in serum creatinine is a biased metric for the study of cardio-renal interactions The risk for chronic kidney disease in patients with heart diseases: a 7-year follow-up in a cohort study in Taiwan.Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure.Cardiorenal syndromes: pathophysiology to prevention Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure.The growth of acute kidney injury: a rising tide or just closer attention to detail?Relation of worsened renal function during hospitalization for heart failure to long-term outcomes and rehospitalization.The cardiorenal syndrome: a review Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival.Cardiorenal syndromes.Long-term effects and prognosis in acute heart failure treated with tolvaptan: the AVCMA trial Acute heart failure volume control multicenter randomized (AVCMA) trial: comparison of tolvaptan and carperitide Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study.

P2860

Q26772195-133D87F8-E914-48A0-AF0E-13D288CFB174 Q26822738-80D160C0-5E47-4670-BB91-FB03FBE54F82 Q27011043-A5C8A728-7855-42BD-A36A-A39398FB7A86 Q27023089-FDF48D43-58CD-4B5B-A72E-9F1569D04719 Q27028203-64175699-22E1-464E-B201-6180AF7F4865 Q28067064-FC3E9A46-EDBD-4D0E-A267-0FA42D5B9504 Q28212766-31B6CD07-6674-4E5C-89FA-B947DF21983D Q28253255-E578D66B-6FB3-4F7F-9BF4-E3F509E8296B Q30223904-65BAF738-0F05-47CF-9140-EAECF3A9B294 Q30315923-B636981A-D5A7-4743-8FA2-277F5F538465 Q30361766-76737F0F-E3BE-4BF1-81F0-2C017EB6F390 Q30878953-F008238A-A2B9-4AD7-9C9A-1AA52CE4006F Q31122131-FD982457-27F2-45C3-8ABE-9D69B9887DCC Q33566655-A7FCD0AA-DF81-44BA-8A7C-8646C777A2E7 Q33698744-21074764-3457-42AF-A864-B111F98FFD9E Q33728260-0B851B58-674C-43A4-8B93-4573E2F5DED2 Q33799444-04DC7C05-8A46-491E-A75F-CF813C8ADD15 Q33799478-ED4EB9C3-D788-4837-B613-C9CF0E5B8C77 Q33964843-E45D538D-BC68-448A-84F4-376EAAFA1806 Q34079591-901F29CA-4C35-4797-A960-0CF7920A0AB3 Q34149704-BDB5AFFF-7AD6-4569-B782-0EDA3A82A438 Q34160755-F98677B2-E122-46C6-9D07-DD4825CA9660 Q34181036-D8CDD3BA-6473-40E7-A7D4-FBBDF3CBF2F2 Q34264037-8C067A96-1C7B-48FB-A088-FC13ABB6A57B Q34292920-D6280101-8599-422B-BEC5-5CA6C327BF24 Q34322180-5ED48D9B-C9E3-46B3-89D3-B9FEE9DE5AD0 Q34340391-1372504F-DB16-4AF2-B494-6F3343B58643 Q34354535-D70D88D0-26C8-474E-BA4E-2332CF9406A7 Q34366134-80A6ACBE-AF99-4696-AF2C-8B6DAFDA2AE8 Q34372498-CC47C976-D0C6-43EA-A45D-B26D52DE1CBE Q34373061-48E28CC2-A6E3-4C0F-B502-DEF07FA0B4DC Q34380235-6728A925-CC75-4F4F-9AB4-A98396C3C063 Q34439098-A9713F7E-0F29-4D4C-B75F-0261699A25AA Q34470304-D7380BBA-2CA0-4E48-A644-EC89056EC76F Q34495307-151FA3EC-D735-4F3B-B424-7BE8F0B17412 Q34512319-D06ED20B-94F5-4035-9BD3-4AF489FE695B Q34538721-ABCCB839-5C8B-4583-8666-8AA9CA09263B Q34570220-A8FB24EB-9B71-44D4-9945-F71869172250 Q34643664-86073CEE-D206-4630-A14F-28C3E93176A1 Q34765857-09954B7C-89BF-4CD6-BF28-020FE1765CB3

P2860

Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

http://www.wikidata.org/entity/Q33196686

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Incidence, predictors at admis ...... spitalized with heart failure.

@ast

Incidence, predictors at admis ...... spitalized with heart failure.

@en

type

label

Incidence, predictors at admis ...... spitalized with heart failure.

@ast

Incidence, predictors at admis ...... spitalized with heart failure.

@en

prefLabel

Incidence, predictors at admis ...... spitalized with heart failure.

@ast

Incidence, predictors at admis ...... spitalized with heart failure.

@en

P1433

Q33196686-676F1E3E-2B2D-4DF2-9CEF-18ED4E8A69F0

P1476

Q33196686-5BA9830A-548F-4FD2-B61D-9D1D7689E919

P2093

Q33196686-0D08A52B-D324-441B-A4F9-96BFE1C9C204

Q33196686-77EC82D4-77E3-4E98-A1F3-0144CE5C5E95

Q33196686-A43D6FF6-848B-48EA-A153-28074C50F45D

Q33196686-BABE436B-DC14-4AC0-9A10-2982858E3F85

Q33196686-BBB12A65-6E9D-4880-BD17-7E2D2F7856B5

Q33196686-C4A2FFC1-0FFF-4680-B83D-8F02F680E480

Q33196686-D12843E1-8912-4FD4-A574-DF644A9FF2F1

Q33196686-D128DBBB-5E01-4A6D-8197-2BC2344879E7

Q33196686-DAB20EC7-2C73-4FE1-9849-7F411E9979DB

P304

Q33196686-F5293394-BA80-4585-A1E2-3FF047090223

P31

Q33196686-3294698F-ECB4-4CAB-B8AF-3371ED1ADDAB

P356

Q33196686-5A8D5993-A163-4CC0-983A-B948C5B60772

P407

Q33196686-65528ABA-4659-4209-B3F8-8E42FCF66058

P433

Q33196686-5DAC73AF-A3BD-439D-B493-948D1B1C2DDB

P478

Q33196686-92DD0D8B-AA0F-4AE7-9517-14B389D24739

P50

Q33196686-2CD1AC00-C5F6-42EF-811E-34311B8076F3

Q33196686-95677FCB-4393-4644-B407-34F61614832A

Q33196686-D57FA1FD-E75A-4512-8ADD-7365DCF722B6

P577

Q33196686-503821C6-EB8C-4322-A23C-7C6EFAC35DEA

P5875

Q33196686-D7824E4B-C223-47F5-9E77-AEE7ECF504A3

P698

Q33196686-480ADCF4-7F0F-40B1-BA70-2BCE68CD7655

P921

Q33196686-91C6E55B-215A-40E8-8AA1-9723D085A3CD

Q33196686-C13C42ED-EAB0-4B9C-869A-C6D720BE23CB

P356

J.JACC.2003.07.031

P1433

Journal of the American College of Cardiology

P1476

Incidence, predictors at admis ...... spitalized with heart failure.

@en

P2093

Barry M Massie

http://www.w3.org/2001/XMLSchema#string

Daniel E Forman

http://www.w3.org/2001/XMLSchema#string

Evan Loh

http://www.w3.org/2001/XMLSchema#string

James B Young

http://www.w3.org/2001/XMLSchema#string

Lynne Warner Stevenson

http://www.w3.org/2001/XMLSchema#string

Michael W Rich

http://www.w3.org/2001/XMLSchema#string

Stephen S Gottlieb

http://www.w3.org/2001/XMLSchema#string

William T Abraham

http://www.w3.org/2001/XMLSchema#string

Yongfei Wang

http://www.w3.org/2001/XMLSchema#string

P304

61-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2003.07.031

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

Harlan M. Krumholz

Christopher M O'Connor

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8926133

http://www.w3.org/2001/XMLSchema#string

P698

14715185

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization